Federal contract award
HHSO100201600027C
IGF::OT::IGF DIASORIN ZIKA VIRUS IGM AND IGG AUTOMATED IMMUNOASSAYS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.7M |
| Current contract value | $2.7M |
| Potential contract value / ceiling | $2.7M |
| Start date | Aug 23, 2018 |
| Current end date | Oct 31, 2019 |
| Potential end date | Oct 31, 2019 |
| Latest award activity | Aug 23, 2018 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 17, 2022 | P00006 | $0 | ASSIGN A NEW ADMINISTRATIVE CONTRACTING OFFICER FOR REPORTING AND CLOSEOUT PROCESSES. |
| Oct 23, 2019 | P00005 | $0 | DIASORIN ZIKA VIRUS IGM |
| Dec 28, 2018 | 4 | $0 | DIASORIN ZIKA VIRUS IGM |
| Aug 23, 2018 | 3 | $0 | IGF::OT::IGF DIASORIN ZIKA VIRUS IGM AND IGG AUTOMATED IMMUNOASSAYS |
| Oct 31, 2017 | 2 | $0 | DIASORIN ZIKA VIRUS IGM AND IGG AUTOMATED IMMUNOASSAYS |
| Oct 19, 2017 | 1 | $0 | DIASORIN ZIKA VIRUS IGM AND IGG AUTOMATED IMMUNOASSAYS |
| Aug 17, 2016 | 0 | $2.7M | IGF::OT::IGF DIASORIN ZIKA VIRUS IGM AND IGG AUTOMATED IMMUNOASSAYS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.